The Sunday magazine is not intended to replace the Sun's daily print coverage of Las Vegas, according to Greenspun Media Group editor and publisher Brian Greenspun, but will instead complement it with smart reporting comparable to Time or Newsweek.
The magazine is expected to run between 64 and 72 pages, and be printed on newsprint with a glossy cover.
"We believe there is a large readership potential in Las Vegas that does not read the daily newspaper, so The Sunday will fill that need," he said.
The future of the Sun remains uncertain. Last summer, three of the four Greenspun siblings agreed to end a joint operating arrangement with Stephens Media, which owns the rival Las Vegas Review-Journal. Since 2005, the Sun has been delivered as a section within the Review-Journal. The two have separate reporting staffs in separate locations.
Best Electric Utility Companies For 2015: Endeavour International Corp (END)
Endeavour International Corporation (Endeavour), incorporated on January 13, 2000, is an independent oil and gas company engaged in the exploration, development and acquisition of energy reserves in the United States and United Kingdom. The Company has three producing fields in the United Kingdom, including Alba, Bacchus and Bittern, as well as a number of development projects including Rochelle and Columbus. In the United States, the Company has production in the Haynesville and Marcellus, as well as two oil frontier plays in Colorado and Montana. As of December 31, 2012, Endeavour had proved reserves of 71,591 million cubic feet (MMcf) of natural gas and 13,739 thousands of barrels (Mbbls) of crude oil for a combined 25.7 million barrels of oil equivalent (MBOE).
The North Sea is a resource area where it has a development project, producing properties and additional exploration licenses. During 2012, Alba production volumes were impacted by water handling issues. As of December 31, 2012, it held a 30% working interest in its Bacchus field asset, which is operated by Apache Corporation, who owns a 50% working interest. In April and July 2012, it achieved production from the first and second development wells, respectively, on the Bacchus field. The Company�� working interest in the Rochelle area is 44% and it is the operator of the field, which is comprised of Blocks 15/26b, 15/26c and 15/27. Its United States activity has targeted reserve and production growth in shale gas plays, including the Louisiana Haynesville and Pennsylvania Marcellus areas.
The Company is also targeting emerging oil-prone and liquids-rich plays, including the Montana Heath oil play and its new interests in the Colorado Niobrara area. The Company operates and controls the Marcellus assets while retaining a 50% position in its remaining producing Haynesville acreage. The Company has 19 Haynesville Units which held by production with an estimated over 80 remaining gross locations to be developed, dep! ending on development well spacing. The Company has interests in approximately 88,900 net acres in the emerging Heath Shale oil play in Montana, primarily in Rosebud and Garfield Counties.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Wednesday morning, the financial sector proved to be a source of strength for the market. Leading the sector was strength from SouFun Holdings (NYSE: SFUN) and E-House (China) Holdings (NYSE: EJ). In trading on Wednesday, energy shares were relative laggards, down on the day by about 0.67 percent. Among the energy stocks, Endeavour International (NYSE: END)was down more than 22 percent, while TransGlobe Energy (NASDAQ: TGA) tumbled around 6 percent. - [By Paul Ausick]
Stocks on the Move: Alcoa Inc. (NYSE: AA) is up 9.1% at $9.38 after posting a new 52-week high of $9.63 earlier today. Endeavour International Corp. (NYSE: END) is down 14.3% at $6.05 after failing to get any appreciable results from its strategic review. E-commerce China Dangdang Inc. (NYSE: DANG) is down 13.4% at $10.05 after issuing a warning on third-quarter earnings.
Best Electric Utility Companies For 2015: PhotoMedex Inc.(PHMD)
PhotoMedex, Inc., together with its subsidiaries, operates as a skin health company in North America and internationally. It offers disease management and aesthetic solutions to dermatologists, professional aestheticians, and consumers. The company provides no!no! hair removal products; professional products, including capital equipment to physicians and skin care specialists; XTRAC laser products for the treatment of psoriasis and vitiligo; NEOVA formulations for premature skin aging due to UV-induced DNA damage; Omnilux Light-emitting diode (LED) systems to treat wrinkles, acne, minor muscle pain, and pigmented lesions; Lumi�e light therapy equipment, a non-invasive skin care solution for use in non-medical applications primarily salons and spas; and topical lotions to improve the appearance of fine lines, wrinkles, skin tone, and blemishes. It also provides home-use devices under the no!no! brand for various indications, including hair removal, acne treatment, and ski n rejuvenation; and a professional product line for acne clearance, skin tightening, psoriasis care, and hair removal to physician clinics and spas. In addition, the company engages in the development, manufacture, and sale of surgical products, including proprietary free-beam and Contact Laser Systems for surgery. Further, it sells surgical disposables and accessories to hospitals and surgery centers; and repairs, maintains, and provides replacement parts for the company?s products. The company is headquartered in Montgomeryville, Pennsylvania.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on PhotoMedex (Nasdaq: PHMD ) , whose recent revenue and earnings are plotted below. - [By Seth Jayson]
PhotoMedex (Nasdaq: PHMD ) reported earnings on May 8. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), PhotoMedex met expectations on revenues and beat expectations on earnings per share. - [By Monica Gerson]
PhotoMedex (NASDAQ: PHMD) shares dropped 12.09% to $11.27 in pre-market trading after the company reported weaker-than-expected third-quarter results.
- [By Lauren Pollock]
Skin-health company PhotoMedex Inc.(PHMD) issued a dour third-quarter report as it didn’t log any consumer sales to its Japanese distributor, which changed its business model and affected other companies besides PhotoMedex. Unless it generates revenue from Japan, the company’s current-quarter sales are poised to fall short of consensus views. Shares dropped 10% to $11.47 premarket.
Best Medical Stocks For 2015: Beazer Homes USA Inc. (BZH)
Beazer Homes USA, Inc. designs, builds, and sells single-family and multi-family homes. The company offers homes for entry-level, move-up, or retirement-oriented buyers. It also engages in rental of previously owned homes that are purchased and improved by the company. The company sells its homes through commissioned new home sales counselors and independent brokers. It operates in 16 states, including Arizona, California, Delaware, Florida, Georgia, Indiana, Maryland, Nevada, New Jersey, New York, North Carolina, Pennsylvania, South Carolina, Tennessee, Texas, and Virginia. Beazer Homes USA, Inc. was founded in 1985 and is headquartered in Atlanta, Georgia.
Advisors' Opinion:- [By Amanda Alix]
Homebuilders have seen their fortunes rise, too, particularly those playing either end of this particular boom. Luxury builder Toll Brothers (NYSE: TOL ) reported a sweet 46% increase in net income�from the first quarter of 2012, aided by an ability to tack on price increases averaging $26,000 per house�-- bringing the average price of a Toll house to a cool $577,000. Beazer Homes (NYSE: BZH ) is playing the single-family rental end of things, via its Pre-Owned Homes Division, a two-year old venture it started with Kohlberg Kravis Roberts (NYSE: KKR ) .
- [By DAILYFINANCE]
Stan Honda, AFP/Getty ImagesPassersby in front of the New York Stock Exchange on Tuesday, Christmas Eve. NEW YORK -- Stocks rose in a holiday-shortened trading day Tuesday, helped by a report that showed American companies were investing in their businesses at the fastest pace since January. Markets were open for just half a day ahead of the Christmas holiday, and trading volume was extremely light. Roughly 1.3 billion shares changed hands on the New York Stock Exchange, a third of what is traded on a regular day. It was the slowest day of the year. Materials and industrial stocks rose more than the rest of the market after the government reported that orders for long-lasting manufactured products rose 3.5 percent in November, more than economists expected. Core capital goods, a category that tracks business investment, jumped 4.5 percent, the biggest gain since January. DuPont (DD) rose $1.09, or 2 percent, to $63.83 and construction equipment maker Caterpillar (CAT) gained 95 cents, or 1 percent, to $90.91. The Dow Jones industrial average (^DJI) rose 62.94 points, or 0.4 percent, to 16,357.55. The Standard & Poor's 500 index (^GPSC) rose 5.33 points, or 0.3 percent, to 1,833.32 and the Nasdaq composite (^IXIC) rose 6.51 points, or 0.2 percent, to 4,155.42. Stocks have been rising steadily since last Wednesday, when the Federal Reserve surprised investors by announcing it was cutting back its bond-buying program, citing an improving economy. The Fed said it will reduce its bond purchases to $75 billion a month beginning in January, down from $85 billion. The last five days of gains have added to what has been a historic year for stock market investors. The S&P 500 index is up 28.6 percent for 2013, or 30.9 when dividends are included, its best year since 1997. With four trading days left in the year, many traders expect stocks to continue higher until New Year's Eve. "Nothing has derailed this market this year, even with all the bad headlin
- [By Jacob Roche]
Sherwin-Williams, along with some other home-improvement stocks, benefits from being part of that rare breed of stocks that do well when times are good, and still do well when times are bad. If the housing market is good, new homes get built en masse, and those homes need to be painted and floored. Hence, with U.S. housing starts up nearly 90% over the past couple of years, homebuilders KB Homes (NYSE: KBH ) and Beazer Homes (NYSE: BZH ) have seen revenues finally starting to recover, and companies such as Sherwin-Williams and Lumber Liquidators (NYSE: LL ) are being pulled along for the ride.
- [By Sean Williams]
The other factor that'll weigh on Trulia's success or failure is whether or not the homebuilding market is cooperating. Luckily for Trulia, we're seeing continued signs of success across the board with the National Association of Home Builders Housing Market Index coming in at a seven-year high yesterday. KB Home (NYSE: KBH ) , for instance, which focuses on middle-and-upper income first-time and trade-up buyers, saw revenue increase 59% in the first-quarter from the year-ago period as its average selling price vaulted higher by 24%. Even struggling homebuilder Beazer Homes (NYSE: BZH ) , which tends to market toward lower- to middle-income first-time buyers and retired persons, saw its revenue leap 51% as average selling prices added nearly 13% in the second quarter. The point is that low inventory levels are leading to higher home prices and renewed interest in owning a home.
Best Electric Utility Companies For 2015: Bona Film Group Limited(BONA)
Bona Film Group Limited distributes films in the People?s Republic of China. It distributes films to movie theaters, as well as to non-theatrical distribution channels, including DVD and Blu-ray and other home video products; Internet and digital distribution; in-flight entertainment; and cable, satellite, and broadcast televisions. The company also invests in the production of Chinese and Hong Kong films in order to obtain the distribution rights for movie theaters and non-theatrical channels. In addition, Bona Film Group operates six movie theaters in five cities of the People?s Republic of China; operates a talent agency business that represents artists; and involves in film advertising and television production businesses. The company was founded in 2003 and is headquartered in Beijing, the People?s Republic of China.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Bona Film Group (Nasdaq: BONA ) , whose recent revenue and earnings are plotted below. - [By Bryan Murphy]
With just a quick glance at the chart, Bona Film Group Ltd (NASDAQ:BONA) doesn't look like anything other than an erratic mess. When you take a step back and take a look at the longer-term chart of BONA, however, you can see the last several weeks have ushered in a major bullish change of direction for the stock... meaning now's a great time to start wading into a position.
Best Electric Utility Companies For 2015: Sinovac Biotech Ltd.(SVA)
Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines against the hepatitis A, hepatitis B, and influenza viruses in the People's Republic of China. It offers Healive, an inactivated hepatitis A vaccine; Bilive, a combination of hepatitis A and B vaccine; Anflu, a split virus influenza vaccine; and Panflu, a vaccine against the influenza A H1N1 virus. The company's pipeline vaccine candidates include a split viron vaccine, which completed Phase II clinical trials for the H5N1 influenza virus; and a SARS vaccine, which completed Phase I clinical trials for the SARS virus. In addition, its pipeline vaccine candidates that completed the pre-clinical trials comprise human vaccines for EV71, pneumococcal conjugate, haemophilus influenzae type b, meningitis, Japanese encephalitis, chickenpox, mumps, and rubella diseases, as well as rabies vaccine for humans and animals. The company markets and sell s its vaccine products directly to the provincial and municipal disease control and prevention centers. It has a patent license agreement with the National Institutes of Health; distribution agreements with LG Life Sciences, Ltd. and Glovax C.V.; and a pandemic influenza vaccine co-development agreement with the China Center for Disease Control and Prevention. Sinovac Biotech Ltd. was founded in 1999 and is headquartered in Beijing, the People's Republic of China.
Advisors' Opinion:- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biopharmaceutical company Sinovac Biotech (NASDAQ: SVA ) has received the dreaded one-star ranking.
- [By Rich Duprey]
Troubling is that it's a new presence in humans, and while that makes its spread among the populace difficult, scientists fear that it's gaining momentum. Sinovac Biotech (NASDAQ: SVA ) , which was approved to produce vaccines several years ago, jumped almost 7% yesterday as it gears up to mass produce a vaccine to combat the new threat.
- [By Louis Navellier]
LGND is a strong buy at today�� price.
Biotech Stocks to Buy: Sinovac Biotech (SVA)Sinovac Biotech LTD (SVA) is a Chinese biotech company that makes drugs to treat conditions such as hepatitis A, hepatitis B, and influenza viruses. The just announced that the phase three trials of a new drug to fight a virus called EV-71 that causes neurological conditions such hand foot and mouth disease showed great promise. Phase III trial results� EV71 vaccine show that the drug had a 94.8% efficacy rate against EV71-related hand, foot, and mouth disease, and a 100% efficacy rate against EV71-associated hospitalization and against HFMD with neurologic complications.
Best Electric Utility Companies For 2015: Mindspeed Technologies Inc.(MSPD)
Mindspeed Technologies, Inc. designs, develops, and sells semiconductor networking solutions for communications applications in enterprise, fixed and mobile broadband access, metropolitan, and wide-area networks (WAN). The company offers communications convergence processing products that serve as bridges for transporting video, voice, fax, and modem transmissions between circuit-switched and packet-based fixed and mobile networks, and across network boundaries; and offer video and voice over Internet protocol, voice-over-asynchronous transfer mode (ATM), and voice-over-digital subscriber line services, as well as wireline-to-wireless connectivity. These products include the eighth-generation Comcerto family for fiber-access service delivery; and Transcede family of 3G/4G base station baseband processors. It also provides analog transmission devices and switching products, which comprise laser drivers, transimpedance amplifiers, post amplifiers, clock and data recovery cir cuits, signal conditioners, serializers/deserializers, video reclockers, cable drivers, and line equalizers that support storage area network, fiber-to-the-premise, optical transport networks, and broadcast video. In addition, the company offers WAN communications products comprising transmission solutions and ATM/multi-protocol label switching network processors that facilitate the aggregation, processing, and transport of voice and data traffic over copper wire or fiber optic cable to access metropolitan and long-haul networks. It sells its products directly to network infrastructure original equipment manufacturers; and indirectly through electronic component distributors and third-party electronic manufacturing service providers in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company was founded in 2001 and is headquartered in Newport Beach, California.
Advisors' Opinion:- [By Monica Gerson]
Mindspeed Technologies (NASDAQ: MSPD) surged 69.02% to $5.02 in the pre-market session after M/A-Com Technology Solutions Holdings (NASDAQ: MTSI) announced its plans to acquire Mindspeed Technologies.
- [By Lauren Pollock]
M/A-COM Technology Solutions Holdings Inc.(MTSI) agreed to acquire semiconductor manufacturer Mindspeed Technologies Inc.(MSPD) in a deal valued at $272 million, expanding the company’s markets to include enterprise applications. Mindspeed shares surged 70% to $5.04 premarket.
- [By Lee Jackson]
Mindspeed Technologies Inc. (NASDAQ: MSPD) provides voice over internet protocol (VOIP) infrastructure and some telecom chips, which account for about 10% of sales. This could disrupt earnings at a micro cap tech company. The consensus price target for the stock is $3.75.
Best Electric Utility Companies For 2015: Synergetics USA Inc.(SURG)
Synergetics USA, Inc., a medical device company, engages in the design, manufacture, and marketing of microsurgical instruments and consumables primarily for ophthalmology and neurosurgery markets in the United States and internationally. The company?s product lines focus upon precision engineered, microsurgical, handheld devices, and the microscopic delivery of laser energy, ultrasound, electrosurgery, aspiration, illumination and irrigation that are delivered in multiple combinations. It offers retinal surgical items, including handheld disposable and reusable forceps and scissors, fiberoptics for illumination and photocoagulation, cannulas, scrapers, and other reusable and disposable surgical devices. The company also provides bipolar electrosurgical generators; lesion generators used for minimally invasive pain treatment; and directional laser probes, as well as offers gauge instrumentation to the vitreoretinal surgical market. It sells its products through direct sale s employees, distributors, and independent sales representatives. The company was founded in 1991 and is headquartered in O?Fallon, Missouri.
Advisors' Opinion:- [By Monica Gerson]
Synergetics USA (NASDAQ: SURG) reported its FQ4 earnings of $0.06 per share on revenue of $17.9 million. However, analysts were projecting earnings of $0.05 per share on revenue of $17 million. Synergetics USA shares dipped 11.82% to $4.40 in the after-hours trading session.
- [By Ben Levisohn]
Synergetics USA (SURG) has dropped 4.8% to $4.75 after the medical device company said it earned 6 cents a share, in line with analyst forecasts.
Team Inc.�(TISI) has dropped 11% after the company missed its earnings forecast and lowered guidance.
- [By Monica Gerson]
Synergetics USA (NASDAQ: SURG) is projected to post its Q4 earnings at $0.06 per share on revenue of $17.01 million.
Team (NYSE: TISI) is expected to post its Q1 earnings at $0.36 per share on revenue of $176.70 million.
Best Electric Utility Companies For 2015: Brandenburg Energy Corp (BBM)
Brandenburg Energy Corp. is engaged in the business of acquiring and exploring oil and gas properties. The Company�� properties include Holloman Cooper Basin Joint Venture, VG Mineral Claims, Senn Property, Exploration License No. 0932, Labana Property and African Properties. The Senn Property earns a 100% interest on the Senn Block of mineral claims (the Senn Property) located in the District of Kenora, Ontario, Canada. The Uganda-based East African Gold Sniffing Company Limited (EA Gold) is a holder of Mineral Exploration License No. 0932 (EL 0932) covers about two square kilometers. EL 0932 lies 287 kilometers southwest of the Ugandan capital, Kampala, 29 kilometers north of the city of Kasese, in Kasese province. The Labana Property consists of four oil and gas blocks in the Republic of Niger, which includes Dibeilla 1, Dibeilla 2, Dalo, and Mandaram. Advisors' Opinion:- [By Muhammad Bazil]
The value of BlackBerry�� stock was at $7.44 as of yesterday�� (Jan. 1, 2014) close. Although this is still a far cry from its 52-week peak of $18.32, it does represent a month-long recovery coming shortly after the launch of its new BlackBerry Messenger (BBM) application for iPhones and Android devices.
Best Electric Utility Companies For 2015: Illumina Inc.(ILMN)
Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Its instrumentation products include HiSeq 2000, an instrument for high-throughput (up to 200 Gb per run and up to 25 GB per day) sequencing using sequencing-by-synthesis (SBS) technology; Genome Analyzer IIx, an instrument for medium to high-throughput (up to 95 Gb per run) sequencing using SBS technology; Genome Analyzer IIe, an instrument for low to medium throughput (up to 40 Gb per run) sequencing using SBS technology; iScan System, a high-resolution imaging instrument to scan BeadArray based assays; and BeadXpress Reader, a low- to mid-multiplex, high-throughput instrument for readout of assays. The company?s consumables consist of InfiniumHD Whole-Genome BeadChips comprising HumanOmniExpress, HumanOmni1-Quad, Human1M-Duo, and BovineHD, which are multi-sample DNA analysis microarrays; iSelect Custom Genotyping BeadChips that are custome r designable SNP genotyping arrays; GoldenGate Assay Method, a high throughput assay and genotyping system; GoldenGate Universal-32 Sample BeadChip, which are 32 sample GoldenGate genotyping arrays; Paired-End Genomic DNA Sample Prep Kit, a streamlined library preparation kit to generate 200?500 kb insert paired-end reads; VeraCode GoldenGate that are low plex GoldenGate genotyping arrays compatible with the BeadXpress System; Standard Sequencing Kit, reagents used for SBS chemistry on sequencing platforms; and Infinium Assay Kit, reagents used to perform Infinium assays on the iScan platform. It also provides sequencing and genotyping services. The company?s customers include pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products companies, as well as research centers. It sells its products through distributors in North America, Europe, the Asia-Pacific, the Middle East, and South Africa. Illumina was founded in 1998 and is headquartered in San Dieg o, California.
Advisors' Opinion:- [By Anders Bylund]
Back in 2003, Illumina (NASDAQ: ILMN ) was a micro-cap specialist in genetic testing with negative earnings and more debt than cash. The company almost went under while waiting for the genetic-testing market to mature. Now it's a hot name in a red-hot health-care market. Long-term shareholders have pocketed an outsized 4,600% return in 10 years, while the Dow Jones Industrial Average (DJINDICES: ^DJI ) gained just 65%.
No comments:
Post a Comment